The STAT3-activating cytokine IL-6 is upregulated in the serum and exhaled breath condensate of NSCLC patients and correlates with a higher risk of metastasis and chemotherapy resistance [118,119,120,121,122,123,124,125]. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.